Azita Saleki-Gerhardt
Chief Operating Officer en ABBVIE INC. .
Fortuna: 44 M $ al 31/03/2024
Cargos activos de Azita Saleki-Gerhardt
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| ENTEGRIS, INC. | Director/Board Member | 14/08/2017 | - |
| Independent Dir/Board Member | 14/08/2017 | - | |
| ABBVIE INC. | Chief Operating Officer | 01/07/2023 | - |
| Corporate Officer/Principal | 29/06/2023 | 01/07/2023 | |
AbbVie Deutschland GmbH & Co. KG
 AbbVie Deutschland GmbH & Co. KG BiotechnologyHealth Technology Part of AbbVie, Inc., AbbVie Deutschland GmbH & Co. KG is a German company that focuses on treating plaque psoriasis, a chronic inflammatory skin disease that cannot be cured but can be managed effectively. The private company is based in Wiesbaden, Germany. The CEOs of the company are Thomas Scheidmeir, Stefan Simianer. | Chairman | - | - |
| United Way of Lake County | Director/Board Member | - | - |
Historial de carrera de Azita Saleki-Gerhardt
Antiguos cargos conocidos de Azita Saleki-Gerhardt.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| ABBOTT LABORATORIES | Corporate Officer/Principal | 01/01/2004 | 01/01/2012 |
Formación de Azita Saleki-Gerhardt.
| University of Wisconsin | Doctorate Degree |
Estadísticas
Internacional
| Estados Unidos | 6 |
| Alemania | 2 |
Operativa
| Corporate Officer/Principal | 2 |
| Director/Board Member | 2 |
| Independent Dir/Board Member | 1 |
Sectorial
| Health Technology | 4 |
| Producer Manufacturing | 2 |
| Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 3 |
|---|---|
| ABBOTT LABORATORIES | Health Technology |
| ENTEGRIS, INC. | Producer Manufacturing |
| ABBVIE INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
| United Way of Lake County | |
AbbVie Deutschland GmbH & Co. KG
AbbVie Deutschland GmbH & Co. KG BiotechnologyHealth Technology Part of AbbVie, Inc., AbbVie Deutschland GmbH & Co. KG is a German company that focuses on treating plaque psoriasis, a chronic inflammatory skin disease that cannot be cured but can be managed effectively. The private company is based in Wiesbaden, Germany. The CEOs of the company are Thomas Scheidmeir, Stefan Simianer. | Health Technology |
